Enhanced Entry Airport Screening and Routing for Ebola to End for Travelers from Guinea to the U.S.
On Feb. 19, 2016, the Centers for Disease Control and Prevention (CDC) and the Department of Homeland Security (DHS) removed Guinea from the list of nations affected by Ebola for which travelers are subject to enhanced U.S. visa and port-of-entry screening. When Guinea is removed from enhanced entry screening, travelers from that country to the United States will no longer be routed through designated U.S. airports and will be able to enter the country through any available port of entry. Guinea will be the last of the affected countries in West Africa to be removed from enhanced entry screening measures.
Travelers departing Guinea will remain subject to outbound screening measures, and the United States will continue to support Guinea’s Ebola prevention and detection measures, including at its primary international airport in Conakry. Travelers from Guinea, Liberia, and Sierra Leone are still encouraged to watch their health for 21 days after leaving one of these countries and to contact their local health departments or seek healthcare if they develop symptoms consistent with Ebola.
On Dec. 29, 2015, the World Health Organization (WHO) declared Guinea free of Ebola virus transmission. This date marked 42 days (two 21-day incubation periods) after the last known patient with Ebola tested negative twice for Ebola. As of Feb. 19, 2016, more than 45 days have passed since WHO declared Guinea free of Ebola virus transmission. Guinea was the last country in the region to reach that milestone.
Source: CDC
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
